UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • May

    31

    Go Behind The Mystery of Myasthenia Gravis On Myasthenia Gravis Awareness Month

    May

    31

    Empowering the Hidradenitis Suppurativa Community: UCB's Triple Approach

    May

    23

    UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in Moderate-to-Severe Hidradenitis Suppurativa

    May

    10

    Moms Really Can Do It All - Meet Tracy: a Mom, Caregiver, Neuroscientist, and Advocate in the Rare Disease Community

    May

    06

    Evolving Expectations for Arthritis Management